Price movement over the last 24 hours
Asuransi Multi Artha Guna Tbk vs Central Proteina Prima Tbk. — how do they compare? Asuransi Multi Artha Guna Tbk trades at Rp390 (market cap 1.95T, 34.6K 24h volume), while Central Proteina Prima Tbk. trades at Rp50 (market cap 2.98T, 3.7M 24h volume). The key difference: Central Proteina Prima Tbk. is the larger of the two by market cap, and Central Proteina Prima Tbk. is more actively traded (3.7M versus 34.6K). Which is the better fit depends on your goals.
| AMAG | CPRO | |
|---|---|---|
Market Cap | 1.95T | 2.98T |
Volume | 34.6K | 3.7M |
Lot | 346 | 36.97K |
Turnover | 13.4M | 184.87M |
Average Price | 387.42 | 50 |
Value | 13.4M | 184.87M |
Indicative Equilibrium Price | 390 | 50 |
Indicative Equilibrium Volume | 300 | 405 |
Trailing returns across standard periods
Latest headlines on both assets
PT Asuransi Multi Artha Guna Tbk (the company) was established at Nov 14, 1980 in Surabaya and at Sept 5, 1997 was moved to Jakarta. The Company's articles of association has been amended from time to time, the latest amendment regarding the change in the Company's status from private company to public company.
Read more on AMAG →PT Central Proteinprima Tbk (The Company) was established on April 30, 1980 based on the Domestic Capital Investment Law No. 6 year 1968. Base on notarial deed no. 45 dated Dec 7, 1989 the company's share holders agreed offering 1.000.000 share to public, increase paid up capital and authorized capital. At 14 May 1990, the company's shares were treadeable in Jakarta Stock Exchange.Base on notarial deed no.7 dated 4 Oct 2004 of Fahiah Helmi, SH, the company was changed to private company. At Nov 5, 2004, base on JSX letter no S-1671/BEJ-PSR/11-2004 the company was delisted. And then at Sep 2004, the Company's ownership was changed to foreign investment. The Company’s articles of association has been amended several times, most recently by notarial deed No. 57 of Lies Herminingsih, S.H., dated Sep 30, 2006, concerning change of director's job description.
Read more on CPRO →